Login

Christophe INIZAN of La Française AM discusses European commercial real estate investment strategies. 00:10:00

Share On Facebook Share On Twitter

Guillaume CADIOU is Chairman of La Française Group

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
SiTime CEO Rajesh Vashist joins Jill Malandrino on Nasdaq #TradeTalks to discuss the precision timing category and its impact.
00:10:00
Fireside Chat with David Foulkes: Brunswick CEO at The Boat Show | David M. Foulkes - CEO of Brunswick Corp
00:10:00
Morgan's adviser Chris Titley recently interviewed Vik Bansal, CEO of Cleanaway (ASX: CWY), who has been with the company since July, discussing his tenure and insights into the business.
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Investing Basics: Why You Should Start Now with Laurel Hardy | Laurel Hardy, CEO, Bespoke Wealth Management.
00:10:00
Copper Supply Dynamics: Challenges and Outlook
00:10:00
Renewable Energy and Safety: A Conversation with Aboitiz Power's CEO | Manny Rubio, CEO, Aboitiz Power Corporation.
00:00:00
Dr. Elliot Goldstein, President and CEO of ProMIS Neurosciences
00:10:00
Maximize Your Investment Returns with Bernard Wealth Management
00:10:00
Wonderla's Vision Ahead: MD Arun Chittilappilly Talks Attractions and Business Strategy | Arun Chittilappilly , Managing Director, Wonderla Holidays Ltd.
00:10:00
Startup Ready/ Industry Ready Achieving Innovation Synergies Across the Divide|Brendon Kim,Head of Investments, Samsung Next
00:10:00
Weekly Economic Update: Market Volatility, Fed Expectations, and Q2 Earnings

© 2026 Nehu